These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21719865)

  • 1. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles.
    Brandt FS; Cazzaniga A; Baumann L; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Rohrich RJ; Werschler WP
    Aesthet Surg J; 2011 Jul; 31(5):521-8. PubMed ID: 21719865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subject global evaluation and subject satisfaction using injectable poly-L-lactic acid versus human collagen for the correction of nasolabial fold wrinkles.
    Brown SA; Rohrich RJ; Baumann L; Brandt FS; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Werschler WP
    Plast Reconstr Surg; 2011 Apr; 127(4):1684-1692. PubMed ID: 21460676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles.
    Narins RS; Baumann L; Brandt FS; Fagien S; Glazer S; Lowe NJ; Monheit GD; Rendon MI; Rohrich RJ; Werschler WP
    J Am Acad Dermatol; 2010 Mar; 62(3):448-62. PubMed ID: 20159311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of injectable poly-L-lactic acid from the correction of HIV-related facial lipoatrophy to aging-related facial contour deficiencies.
    Burgess C
    J Drugs Dermatol; 2011 Sep; 10(9):1001-6. PubMed ID: 22052268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional digital surface imaging measurement of the volumizing effect of injectable poly-L-lactic acid for nasolabial folds.
    Lowe P; Lowe NJ; Patnaik R
    J Cosmet Laser Ther; 2011 Apr; 13(2):87-94. PubMed ID: 21401382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy.
    Moyle GJ; Brown S; Lysakova L; Barton SE
    HIV Med; 2006 Apr; 7(3):181-5. PubMed ID: 16494632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retreatment with injectable poly-l-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study.
    Mest DR; Humble GM
    Dermatol Surg; 2009 Feb; 35 Suppl 1():350-9. PubMed ID: 19207325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decade of experience with injectable poly-L-lactic acid: a focus on safety.
    Bartus C; William Hanke C; Daro-Kaftan E
    Dermatol Surg; 2013 May; 39(5):698-705. PubMed ID: 23379657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
    Bassichis B; Blick G; Conant M; Condoluci D; Echavez M; Eviatar J; Gold MH; Hamilton T; Hanke CW; Humble G; LaMarca A; Daro-Kaftan E; Mest D; Pierone G
    Dermatol Surg; 2012 Jul; 38(7 Pt 2):1193-205. PubMed ID: 22759256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correction of nasolabial fold: a randomized, evaluator-blinded, comparative study.
    Hyun MY; Lee Y; No YA; Yoo KH; Kim MN; Hong CK; Chang SE; Won CH; Kim BJ
    Clin Exp Dermatol; 2015 Mar; 40(2):129-35. PubMed ID: 25319932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ArteFill: a long-lasting injectable wrinkle filler material--summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes.
    Cohen SR; Berner CF; Busso M; Gleason MC; Hamilton D; Holmes RE; Romano JJ; Rullan PP; Thaler MP; Ubogy Z; Vecchione TR
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):64S-76S. PubMed ID: 16936546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience.
    Butterwick K; Lowe NJ
    J Am Acad Dermatol; 2009 Aug; 61(2):281-93. PubMed ID: 19615539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume.
    Schierle CF; Casas LA
    Aesthet Surg J; 2011 Jan; 31(1):95-109. PubMed ID: 21239677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the aged hand with injectable poly-l-lactic acid.
    Rendon MI; Cardona LM; Pinzon-Plazas M
    J Cosmet Laser Ther; 2010 Dec; 12(6):284-7. PubMed ID: 21142738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Canadian study of the use of poly-L-lactic acid dermal implant for the treatment of hill and valley acne scarring.
    Sapra S; Stewart JA; Mraud K; Schupp R
    Dermatol Surg; 2015 May; 41(5):587-94. PubMed ID: 25915626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial volumetric correction with injectable poly-L-lactic acid.
    Vleggaar D
    Dermatol Surg; 2005 Nov; 31(11 Pt 2):1511-7; discussion 1517-8. PubMed ID: 16416633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience.
    Mest DR; Humble G
    Dermatol Surg; 2006 Nov; 32(11):1336-45. PubMed ID: 17083585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly-L-lactic acid: a new dimension in soft tissue augmentation.
    Rotunda AM; Narins RS
    Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid.
    Goldberg D; Guana A; Volk A; Daro-Kaftan E
    Dermatol Surg; 2013 Jun; 39(6):915-22. PubMed ID: 23464798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: the positive impact of evolving methodology.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s32-4. PubMed ID: 24719075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.